Participants using tirzepatide lost 22.8 kg and participants on semaglutide lost 15.0 kg SURMOUNT-5 compared tirzepatide, a dual GIP and GLP-1 receptor agonist, to semaglutide, a mono GLP-1 receptor agonist in adults living with obesity without diabetes Eli Lilly and Company (NYSE: LLY) today announced topline results
In a compelling address marking the 78th Independence Day, Prime Minister Shri Narendra Modi unveiled a series of visionary goals designed to steer India towards unprecedented growth and global leadership. His speech outlined a strategic roadmap aimed at transforming various sectors, with a notable emphasis
By: Dr Arjun AL, MBBS, Vice President, DailyRounds, Bengaluru, India As the global medical landscape continues to evolve, the United Kingdom remains an attractive destination for Indian medical graduates (IMGs) seeking to expand their horizons and pursue career opportunities abroad. The surge in international medical graduates joining
Designed and manufactured in India, for the world, TheruptorTM Novo by Healthium is a patented wound dressing product that provides conducive wound healing environment for chronic wounds Healthium Medtech, a global medical devices company focused on surgical, post-surgical and chronic care, today announced that the company
